FDA Approved: FYARRO — Original Application (Aadi Bioscience, Inc.)

View source ↗

Summary

FDA approved FYARRO (sirolimus) from Aadi Bioscience in an original application for the treatment of adult patients with malignant perivascular epithelioid cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Perivascular Epithelioid Cell Tumor

Drugs mentioned

• FYARRO (sirolimus)

Snippet

ORIG AP for FYARRO (SIROLIMUS)